NCT00251771View on ClinicalTrials.gov

Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis

NACompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Deep Vein Thrombosis
Interventions
PROCEDURE

catheter-directed venous thrombolysis

catheter-directed continuous intravenous infusion of alteplase 0.01mg/kg/h and low-dose heparin. Max dose 20mg/24 h and up to 96 hrs.

Trial Locations (1)

0407

Ullevaal University Hospital, Oslo

All Listed Sponsors
collaborator

Ostfold Hospital Trust

OTHER

lead

Oslo University Hospital

OTHER

NCT00251771 - Catheter-Directed Venous Thrombolysis in Acute Iliofemoral Vein Thrombosis | Biotech Hunter | Biotech Hunter